<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Updates From 2022 SABCS Underscore the Continued Expansion of Treatment Options in Metastatic Breast Cancer

by OncLive | January 18, 2023
placeholder

The 2022 San Antonio Breast Cancer Symposium highlighted research and treatments for HER2-negative, HER2-low, and HER2-positive breast cancer.

Topics: Press Coverage

Comments